Pharmacokinetics of tablet and liquid formulations of oral 6-mercaptopurine in children with acute lymphoblastic leukemia

被引：0
|
作者：
Rikke Hebo Larsen
Lisa Lyngsie Hjalgrim
Kathrine Grell
Kim Kristensen
Line Gerner Pedersen
Emilie Damgaard Brünner
Bodil Als-Nielsen
Kjeld Schmiegelow
Jacob Nersting
机构：
[1] University Hospital Rigshospitalet,Department of Pediatrics and Adolescent Medicine
[2] University of Copenhagen,Section of Biostatistics, Department of Public Health
[3] Novo Nordisk,Discovery and Development PKPD
[4] University of Copenhagen,Institute of Clinical Medicine, Faculty of Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2020年 / 86卷
关键词：
Childhood acute lymphoblastic leukemia; Leukemia; Cancer; Mercaptopurine; Pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：25 / 32
页数：7
相关论文
共 50 条
  • [21] Isolated decrease in factor V in children treated by 6-Mercaptopurine for acute lymphoblastic Leukemia
    Filhon, B.
    Dumesnil, C.
    Van Dreden, P.
    Schneider, P.
    Vasse, M.
    Vannier, J. P.
    THROMBOSIS RESEARCH, 2014, 134 (05) : 1164 - 1166
  • [22] 6-MERCAPTOPURINE DOSAGE REDUCTION AND TPMT POLYMORPHISMS IN THE TREATMENT OF CHILDREN ACUTE LYMPHOBLASTIC LEUKEMIA
    Ferreira Baptista, A.
    Coucelo, M.
    Garrido, T.
    Mendes, M. J.
    Marini, S.
    Saturnino, H.
    Silva, S.
    Brito, M. J.
    Benedito, M.
    Ribeiro, M. L.
    HAEMATOLOGICA, 2014, 99 : 277 - 277
  • [23] Isolated decrease of factor v in children treated by 6-mercaptopurine for acute lymphoblastic leukemia
    Filhon, B.
    Dumesnil, C.
    Van Dreden, P.
    Compagnon, P.
    Adam, M.
    Schneider, P.
    Vasse, M.
    Vannier, J. P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 471 - 472
  • [24] Evaluation of FTO polymorphism in 6-mercaptopurine related intolerance in children with acute lymphoblastic leukemia
    Minu Singh
    Divya Bhaskar
    Prateek Bhatia
    Rozy Thakur
    Pankaj Sharma
    Deepak Bansal
    Richa Jain
    Amita Trehan
    Cancer Chemotherapy and Pharmacology, 2023, 92 : 51 - 56
  • [25] Pharmacokinetics and distribution of 6-mercaptopurine administered intravenously in children with lymphoblastic leukaemia
    JacqzAigrain, E
    Nafa, S
    Medard, Y
    Bessa, E
    Lescoeur, B
    Vilmer, E
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 53 (01) : 71 - 74
  • [26] Pharmacokinetics and distribution of 6-mercaptopurine administered intravenously in children with lymphoblastic leukaemia
    E. Jacqz-Aigrain
    S. Nafa
    Y. Médard
    E. Bessa
    B. Lescoeur
    E. Vilmer
    European Journal of Clinical Pharmacology, 1997, 53 : 71 - 74
  • [27] A novel 6-mercaptopurine oral liquid formulation for pediatric acute lymphoblastic leukemia patients - results of a randomized clinical trial
    Hanff, Lidwien M.
    Mathot, Ron A. A.
    Smeets, Oscar
    Postma, Doerine J.
    Ramnarain, Satianand
    Vermes, Andras
    Pieters, Rob
    Zwaan, C. Michel
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (08) : 653 - 662
  • [28] Impact of morning versus evening schedule for oral methotrexate and 6-mercaptopurine on relapse risk for children with acute lymphoblastic leukemia
    Schmiegelow, K
    Glomstein, A
    Kristinsson, J
    Salmi, T
    Schroder, H
    Bjork, O
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1997, 19 (02) : 102 - 109
  • [29] 6-MERCAPTOPURINE IN CEREBROSPINAL-FLUID DURING ORAL-MAINTENANCE THERAPY OF CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    HAYDER, S
    LAFOLIE, P
    BJORK, O
    AHSTROM, L
    PETERSON, C
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1988, 5 (03): : 187 - 189
  • [30] Myelotoxicity, pharmacokinetics, and relapse rate with methotrexate/6-mercaptopurine maintenance therapy of childhood acute lymphoblastic leukemia
    Schmiegelow, K
    Ifversen, M
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1996, 13 (05) : 433 - 441
12345